Manuel J Glynias

Mr. Glynias is a serial entrepreneur with over 25 years of experience in bioinformatics. Immediately prior to GenomOncology, Manuel was a partner at Rosetta, a leading interactive marketing agency, where he helped develop big data solutions for ecommerce clients. In the late 90’s, Manuel was the founder and CEO of NetGenics, a venture-backed provider of discovery informatics to the biopharmaceutical industry and academic research centers. He also developed a number of other commercial software platforms including MacGene, Gene Works, and Primer Express. Manuel has an AB in Biochemistry and Molecular Biology from Harvard College.

Victor Peroni

Victor Peroni

Chief Financial Officer, is an accomplished senior executive with 24+ years of business experience ranging from Finance and Operations to Sales and Marketing.  Prior to joining GO, Vic served as President of Hebron USA, Corp and COO of Ganeden Biotech.  He has worked at various startups, as well as more established companies that have included private, international, angel and venture investor groups.  Vic has also helped to grow and position various companies for merger or acquisition.  He has worked with some of the largest retailers in the world including Walmart, Walgreens and CVS and holds a BA in Accounting from Baldwin-Wallace University.

Kelly Choi, MD

Chief Commercial Officer, Dr. Kelly Choi has over 20 years of healthcare experience most recently as one of the founding members of Cota, Inc a healthcare technology company focused on measuring real-world clinical and cost outcomes in oncology.  In addition, she held various executive roles at healthcare technology company QuantiaMD (now part of Aptus Health).  Other experience includes Novartis Pharmaceuticals and McKinsey & Company.  She holds an medical degree from Northwestern University and is trained in internal medicine and cardiology from Northwestern and Duke respectively.


Teresa Fletcher, CHP

Vice President of Business Development, is a seasoned business development professional with a deep understanding of oncology and the healthcare ecosystem. Teresa has over 17 years experience with enterprise solution sales within the healthcare provider space along with a comprehensive knowledge and expertise pertaining to maximizing the effectiveness of healthcare data, managing outcomes, and informatics strategy. Prior to joining GenomOncology, Teresa has held positions in various healthcare startups within sales and customer management in the healthcare IT, healthcare informatics, and medical device industries. Teresa received her Bachelor of Arts from Lafayette College and is a Certified HIPAA Professional who serves in an advisory role to many of her provider clients with her experience in data protection and data sharing.

Ian Maurer

Vice President of Product Development, leads the full lifecycle of application design, architecture, development, and quality assurance. Ian has 17 years of software development and leadership experience working for Lockheed Martin, Ernst & Young, Brulant and Rosetta. He has his Bachelors and Masters degrees in Computer Engineering from Syracuse University.